These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8357945)

  • 21. Strategies for the identification, control and determination of genotoxic impurities in drug substances: a pharmaceutical industry perspective.
    Raman NV; Prasad AV; Ratnakar Reddy K
    J Pharm Biomed Anal; 2011 Jun; 55(4):662-7. PubMed ID: 21193280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overall impact of the regulatory requirements for genotoxic impurities on the drug development process.
    Giordani A; Kobel W; Gally HU
    Eur J Pharm Sci; 2011 May; 43(1-2):1-15. PubMed ID: 21420491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current good manufacturing practice: proposed revision of certain requirements for finished pharmaceuticals; proposed rule, May 3, 1996 (61 FR 20103), [Docket No. 95N-0362]. Parenteral Drug Association.
    PDA J Pharm Sci Technol; 1996; 50(6):346-51. PubMed ID: 9038078
    [No Abstract]   [Full Text] [Related]  

  • 24. Lessons from contaminated heparin.
    Dodd S; Besag FM
    Curr Drug Saf; 2009 Jan; 4(1):1. PubMed ID: 19149518
    [No Abstract]   [Full Text] [Related]  

  • 25. Regulators scramble to tighten loopholes after heparin debacle.
    Jia H
    Nat Biotechnol; 2008 May; 26(5):477-8. PubMed ID: 18464756
    [No Abstract]   [Full Text] [Related]  

  • 26. Walking the drug regulatory tightrope.
    Dove A
    Nat Biotechnol; 2003 May; 21(5):495-8. PubMed ID: 12721571
    [No Abstract]   [Full Text] [Related]  

  • 27. Contaminant in the recalled unfractionated heparin preparations: where is the problem?
    Hoppensteadt DA; Wahi R; Adiguzel C; Iqbal O; Ramacciotti E; Bick RL; Messmore HL; Bansal V; Fareed J
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):261-6. PubMed ID: 18565985
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug-diversion turf war: will Cardinal ruling reinvent roles, DEA strategy?
    Lee J
    Mod Healthc; 2012 Mar; 42(10):8-9. PubMed ID: 22458066
    [No Abstract]   [Full Text] [Related]  

  • 29. [Internet pharmacies and counterfeit drugs].
    Schweim JK; Schweim HG
    Med Klin (Munich); 2009 Feb; 104(2):163-9. PubMed ID: 19242667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Criminal conviction for distribution of a drug not approved by the FDA.
    Brushwood DB
    Am J Hosp Pharm; 1991 Apr; 48(4):747-9. PubMed ID: 2042679
    [No Abstract]   [Full Text] [Related]  

  • 31. Symposium on drug safety. The role of regulatory agencies and industry in assessment of the safety of drugs for use in man. The situation in the United Kingdom.
    Cahal DA
    Can Med Assoc J; 1968 Feb; 98(6):271-5. PubMed ID: 5636096
    [No Abstract]   [Full Text] [Related]  

  • 32. Dunkel proposals and the medical profession.
    Roy UK
    J Indian Med Assoc; 1993 Nov; 91(11):295-6. PubMed ID: 8138655
    [No Abstract]   [Full Text] [Related]  

  • 33. FDA, industry collaborate to strengthen painkiller restrictions.
    Sipkoff M
    Manag Care; 2009 Apr; 18(4):10-1. PubMed ID: 19472560
    [No Abstract]   [Full Text] [Related]  

  • 34. Coagulation and adulteration--building on science and policy lessons from 1905.
    Avorn J
    N Engl J Med; 2008 Jun; 358(23):2429-31. PubMed ID: 18525040
    [No Abstract]   [Full Text] [Related]  

  • 35. Legalized importation of Canadian prescription drugs: short-term solution to a long-term problem.
    Teufel AT
    J Contemp Health Law Policy; 2006; 22(2):383-408. PubMed ID: 17117702
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulatory paternalism in the market for drugs: lessons from Vioxx and Celebrex.
    Epstein RA
    Yale J Health Policy Law Ethics; 2005; 5(2):741-70. PubMed ID: 16052898
    [No Abstract]   [Full Text] [Related]  

  • 37. Courts favour HIV compensation.
    Nathan R
    Nat Med; 1995 Nov; 1(11):1106. PubMed ID: 7584972
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug and alcohol policy at the global level.
    Anderson P
    Drug Alcohol Rev; 2006 Nov; 25(6):485-7. PubMed ID: 17132568
    [No Abstract]   [Full Text] [Related]  

  • 39. Investigation of the origin of ephedrine and methamphetamine by stable isotope ratio mass spectrometry: a Japanese experience.
    Makino Y; Urano Y; Nagano T
    Bull Narc; 2005; 57(1-2):63-78. PubMed ID: 21338016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Independence or subservience--choice is ours.
    Ray I
    J Indian Med Assoc; 1993 Nov; 91(11):276. PubMed ID: 8138645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.